These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene. Magga J, Sipola P, Vuolteenaho O, Risteli J, Jääskeläinen P, Peuhkurinen K, Kuusisto J. Am J Cardiol; 2008 Apr 15; 101(8):1185-90. PubMed ID: 18394456 [Abstract] [Full Text] [Related]
12. Reduced global myocardial perfusion reserve in DCM and HCM patients assessed by CMR-based velocity-encoded coronary sinus flow measurements and first-pass perfusion imaging. Bietenbeck M, Florian A, Shomanova Z, Meier C, Yilmaz A. Clin Res Cardiol; 2018 Nov 15; 107(11):1062-1070. PubMed ID: 29774406 [Abstract] [Full Text] [Related]
13. Inducibility of life-threatening ventricular arrhythmias is related to maximum left ventricular thickness and clinical markers of sudden cardiac death in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene. Hedman A, Hartikainen J, Vanninen E, Laitinen T, Jääskeläinen P, Laakso M, Peuhkurinen K, Kuusisto J. J Mol Cell Cardiol; 2004 Jan 15; 36(1):91-9. PubMed ID: 14734051 [Abstract] [Full Text] [Related]
20. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. Germans T, Wilde AA, Dijkmans PA, Chai W, Kamp O, Pinto YM, van Rossum AC. J Am Coll Cardiol; 2006 Dec 19; 48(12):2518-23. PubMed ID: 17174192 [Abstract] [Full Text] [Related] Page: [Next] [New Search]